Preparation and use of NHS-MAG3 for technetium-99m labeling of DNA

Nuclear Medicine and Biology

Volumn 24, Issue 5, 1997, Pages 425-432

  Winnard Jr , P ^a   Chang, F ^a   Rusckowski, M ^a   Mardirossian, G ^a   Hnatowich, D J ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

99mTc; Amidothiols; Chelator; Mercaptoacetylglycylglycylglycine

Indexed keywords

MERTIATIDE TC 99M; CHELATING AGENT; DIAGNOSTIC AGENT; DNA; DRUG DERIVATIVE; GLYCINE; N (MERCAPTOACETYL)GLYCINE; N HYDROXYSUCCINIMIDE; N-(MERCAPTOACETYL)GLYCINE; N-HYDROXYSUCCINIMIDE; SUCCINIMIDE DERIVATIVE; TECHNETIUM;

ARTICLE; DRUG CONJUGATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOTOPE LABELING; RADIOCHROMATOGRAPHY; STRUCTURE ACTIVITY RELATION; SYNTHESIS; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

CHELATING AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA; GLYCINE; ISOTOPE LABELING; MAGNETIC RESONANCE SPECTROSCOPY; SUCCINIMIDES; TECHNETIUM;

EID: 85047676667     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(97)80010-8     Document Type: Article

References (19)

1. Abrams M. J., Juweid M., tenKate C. I., Schwartz D. A., Hauser M. M., Gaul F. E., et al. (1990) Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats. J. Nucl. Med. 31, 2022-2028.
2. Benary E. (1913) Thiotetronic acid and derivatives. Ber. 46, 2103-2107.
3. 3 and biodistribution of by-products. Appl. Radiat. Isot. 39, 121-129.
4. Bryson N., Lister-James J., Jones A. G., Davis W. M. and Davison A. (1990) Protecting groups in the preparation of thiolate complexes of technetium. Inor. Chem. 29, 2948-2951.
5. Duncan R. J. S., Weston P. D. and Wrigglesworth R. (1983) A new reagent which may be used to introduce sulfhydryl groups into proteins, and its use in the preparation of conjugates for immunoassay. Anal. Biochem. 132, 68-73.
6. Fasman G. D., ed. (1976) CRC Handbook of Biochemistry and Molecular Biology 3rd edition, Vol 1 CRC Press, Boca Raton, FL. p 321.
7. Fritzberg A. R., Berninger R. W., Hadley S.W., et al. (1988) Approaches to radiolabeling of antibodies for diagnosis and therapy of cancer. Pharmaceutical Res. 5, 325-334.
8. 99mTc-labeling of antibodies. Nuklearmedzin 26, 7-12.
9. 3 as a hippuran replacement. J. Nucl. Med. 27, 111-116.
10. 186Re-labeled NR-LU-10 whole antibody in LS174T colonie tumor-bearing mice. Cancer Res. 50, 7973-7978.
11. Hnatowich D. J., Mardirossian G., Fogarasi M., Sano T., Smith C. L., Cantor C. R., et al. (1996) Comparative properties of a technetium-99m-labeled single-stranded natural DNA and a phosphorothioate derivative in vitro and in vivo in mice. J. Pharmacol. Exp. Ther. 276, 326-334.
12. 99mTc. J. Nucl. Med. 36, 2306-2314.
13. Hnatowich D. J., Virzi F., Fogarasi M., Winnard P. Jr. and Rusckowski M. (1994) Can a cysteine challenge assay predict the in vivo behavior of 99Tc labeled to antibodies? Nucl. Med. Biol. 21, 1035-1044.
14. Hnatowich D. J., Mardirossian G., Ruscowski M., Fogarasi M., Virzi F. and Winnard P. Jr. (1993) Directly and indirectly technetium-99m-labeled antibodies - a comparison of in vitro and animal in vivo properties. J. Nucl. Med. 34, 109-119.
15. 3 and SHNH - an in vitro and animal in vivo comparison. Nucl. Med. Biol. 23, 917-922.
16. 188Re-labeling of monoclonal antibodies. Cancer 73, 769-773.
17. 3-HSA as possible blood pool agents. Nucl. Med. Comm. 16, 942-957.
18. 99mTc-radiolabeled antibody Fab-chelator conjugate. Bioconjugate Chem. 1, 431-437.
19. Wetmur J. G. (1991) DNA probes: Applications of the principles of nucleic acid hybridization. Rev. Biochem. Mol. Biology 26, 227-259.